Riley Petersen delivered an oral presentation at the 67th Experimental NMR Conference (ENC) at Asilomar Conference Ceter, California, titled “Defining Ligand Recognition Mechanisms of CUG Repeat RNA to Enable RNA-Targeted Therapeutics for Myotonic Dystrophy Type 1.” In this talk, Riley highlighted our lab’s recent progress in uncovering the dynamic features of CUG repeat RNA and their role as potential drug-binding pockets, providing important insights for the development of RNA-targeted therapeutics for Myotonic Dystrophy Type 1.
We are excited to see this work gaining visibility within the NMR research community.